跳至主要内容
临床试验/NCT07653139
NCT07653139尚未招募不适用

Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1

研究概览

简要总结

This study aims to generate structured patient preference evidence on prophylactic treatment options for haemophilia A for adults with and without inhibitors to support health technology assessment and benefit evaluation processes. The study will examine how individuals with haemophilia A evaluate trade-offs between treatment effectiveness, safety, and treatment administration characteristics when choosing between prophylactic therapies. Participants will repeatedly choose between hypothetical treatment profiles that differ in clinically relevant attributes and levels.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Participant has the mental capacity and sufficient German language proficiency to understand the study procedures and to complete the survey.
  • Age above or equal to 18 years at the time of signing informed consent.
  • Validated diagnose with haemophilia A, with and without inhibitors.
  • Resident in Germany.

排除标准

  • No provision of informed consent in this study.
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
  • Age below 18 years at the time of signing informed consent.
  • Absence of a diagnosis of haemophilia A.
  • No residence in Germany.

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验